EVGN (EVOGENE LTD.) Stock Analysis - Insider Trades

EVOGENE LTD. (EVGN) is a publicly traded Healthcare sector company. As of May 20, 2026, EVGN trades at $0.72 with a market cap of $8.47M and a P/E ratio of 0.00. EVGN moved +0.00% today. Year to date, EVGN is -34.16%; over the trailing twelve months it is -44.48%. Its 52-week range spans $0.70 to $3.32. Analyst consensus is buy with an average price target of $2.25. Rallies surfaces EVGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading EVGN stock inside the company?

Rallies tracks EVGN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

EVGN Key Metrics

Key financial metrics for EVGN
MetricValue
Price$0.72
Market Cap$8.47M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$3.32
52-Week Low$0.70
Volume31.89K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest EVGN News

EVGN Analyst Consensus

1 analysts cover EVGN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.25.

Common questions about EVGN

Who is trading EVGN stock inside the company?
Rallies tracks EVGN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for EVGN?
Yes. Rallies tracks EVGN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is EVGN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EVGN. It does not provide personalized investment advice.
EVGN

EVGN